Skip to main content

Table 1 Classification of sAMC patients according to current recommendations

From: Abnormal T2 mapping cardiovascular magnetic resonance correlates with adverse clinical outcome in patients with suspected acute myocarditis

 

sAMC

n = 46

Clinical Presentation

 Acute Chest Pain

26 (57%)

 New-onset or worsening of dyspnoea at rest or exercise:

34 (74%)

  NYHA I

12 (26%)

  NYHA II

14 (30%)

  NYHA III

14 (30%)

  NYHA IV

6 (13%)

 Arrhythmia symptoms; Palpitations; Syncope

9 (20%)

 Fatigue

33 (72%)

Diagnostic Criteria

 

 Current Infection

36 (78%)

 Hs-Troponin (ng/ml)

375 ± 512

 Hs-Troponin >14 ng/ml

38 (83%)

 Suspicious ECG (%)

32 (70%)

 Functional and structural abnormalities on cardiac imaging (CMR/Echo)

46 (100%)

  1. Abbreviations: sAMC suspected acute myocarditis, ECG Electrocardiogram, Echo Echocardiography, NYHA New York Heart Association, CMR Cardiovascular Magnetic Resonance
  2. Values represent mean ± standard deviation or percentage